Catheter Ablation of Ventricular Fibrillation
Related Experiment Video
Updated: Feb 4, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Robert D Anderson1, Saurabh Kumar2, Jonathan M Kalman1
1Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Vic, Australia.
Insights
Ventricular fibrillation (VF), a cause of sudden cardiac death, is poorly understood. This review explores VF mechanisms and catheter ablation (CA) as a treatment for VF storms, offering new hope for patients refractory to other therapies.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Ventricular fibrillation (VF) is a life-threatening arrhythmia causing sudden cardiac death (SCD).
- Current treatments like implantable cardioverter defibrillators (ICDs) manage VF episodes but don't prevent recurrences or electrical storms.
- Understanding VF mechanisms is crucial for developing effective therapies.
Purpose of the Study:
- To review recent advancements in understanding the mechanisms initiating and sustaining VF.
- To discuss the evolving role and indications of catheter ablation (CA) for treating VF and VF storms.
Main Methods:
- Literature review focusing on VF mechanisms and catheter ablation outcomes.
- Analysis of current therapeutic strategies for VF and electrical storm.
Main Results:
- VF mechanisms remain incompletely understood due to human mapping challenges.
- Catheter ablation is increasingly utilized for refractory VF storms.
- ICDs are effective for acute VF treatment but do not prevent recurrence.
Conclusions:
- Further research into VF mechanisms is needed.
- Catheter ablation presents a promising therapeutic option for managing recurrent VF and electrical storms.
- Integrating mechanistic insights with ablation strategies may improve patient outcomes.
Abstract:
Ventricular fibrillation (VF) is a common and life-threatening arrhythmia resulting in sudden cardiac death (SCD). Due to the inherent challenges of mapping VF in humans, the underlying mechanisms that initiate and sustain this common arrhythmia are still poorly understood. In high-risk patients and survivors of SCD, implantable cardioverter defibrillators (ICD) play a central role in treating VF episodes, however, ICDs do not prevent VF recurrences and patients remain at risk of electrical storm and multiple shocks that are often refractory to escalation of medical therapy. More recently, the utility of catheter ablation (CA) has extended to the treatment of VF storms. This review will focus on updates in elucidating the mechanism of VF leading into the role and indication of CA as a treatment strategy.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
03:03Amyloid Fibrils
01:11Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:56Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
02:21Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...